Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Open accessIntegrity signals
Registry
Cites
Statistics
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Cited by
Sorted by citations
Advances in COVID-19 mRNA vaccine development
Fang, E., Liu, X., Li, M., Zhang, Z., Song, L., Zhu, B., Wu, X., Liu, J., Zhao, D., & Li, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00950-y · Cited by 601 · see citing works
Zhang, Z., Shen, Q., & Chang, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843928 · Cited by 69 · see citing works
Self-amplifying mRNA vaccines: Mode of action, design, development and optimization
Pourseif, M. M., Masoudi‐Sobhanzadeh, Y., Azari, E., Parvizpour, S., Barar, J., Ansari, R. A., & Omidi, Y. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103341 · Cited by 54 · see citing works
Lichen planus flare following COVID‐19 vaccination: A case report
Herzum, A., Burlando, M., Molle, M. F., et al. (2021) · Clinical Case Reports · doi:10.1002/ccr3.5092 · Cited by 54 · see citing works
Impact of age and comorbidities on SARS-CoV-2 vaccine-induced T cell immunity
Dietz, L. L., Juhl, A. K., Søgaard, O. S., Reekie, J., Nielsen, H., Johansen, I. S., Benfield, T., Wiese, L., Stærke, N. B., Jensen, T. Ø., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00277-x · Cited by 55 · see citing works
SARS‐CoV‐2 vaccination in solid‐organ transplant recipients: What the clinician needs to know
Giannella, M., Pierrotti, L. C., Helanterä, I., & Manuel, O. (2021) · Transplant International · doi:10.1111/tri.14029 · Cited by 43 · see citing works
High-dimensional multi-pass flow cytometry via spectrally encoded cellular barcoding
Kwok, S. J. J., Forward, S., Fahlberg, M. D., Assita, E. R., Cosgriff, S., Lee, S. H., Abbott, G. R., Zhu, H., Minasian, N. H., Vote, A. S., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01144-9 · Cited by 40 · see citing works
Bio-vehicles of cytotoxic drugs for delivery to tumor specific targets for cancer precision therapy
Al-Mansoori, L., Elsinga, P. H., & Goda, S. K. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112260 · Cited by 27 · see citing works
Navalón-López, M., Dols-Pérez, A., Grijalvo, S., Fornaguera, C., & Borrós, S. (2023) · Nanoscale Advances · doi:10.1039/d2na00800a · Cited by 26 · see citing works
Mengüç, K., Aydin, N., & Ulu, M. (2023) · International Journal of Production Research · doi:10.1080/00207543.2023.2182151 · Cited by 22 · see citing works
The mRNA vaccine, a swift warhead against a moving infectious disease target
Mir, S., & Mir, M. A. (2024) · Expert Review of Vaccines · doi:10.1080/14760584.2024.2320327 · Cited by 27 · see citing works
Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy
Damavandi, A. R., Dowran, R., Sharif, S. A., Kashanchi, F., & Jafari, R. (2022) · Medical Microbiology and Immunology · doi:10.1007/s00430-022-00729-6 · Cited by 21 · see citing works
Immunomodulatory Nanomedicine for the Treatment of Atherosclerosis
Peters, L. J. F., Jans, A., Bartneck, M., & van der Vorst, E. P. C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10143185 · Cited by 19 · see citing works
A self-pressure-driven blood plasma-separation device for point-of-care diagnostics
Kim, H., Park, H., Chung, D. R., et al. (2022) · Talanta · doi:10.1016/j.talanta.2022.123562 · Cited by 20 · see citing works
Yoshida, A., Okamura, S., Torii, S., Komatsu, S., Miyazato, P., Sasaki, H., Ueno, S., Suzuki, H., Kamitani, W., Ono, C., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105412 · Cited by 20 · see citing works
Chung, W., Preclaro, I. A. C., Chung, W., & Wang, C. (2022) · Biomedicines · doi:10.3390/biomedicines10061260 · Cited by 18 · see citing works
Nano-Carriers of COVID-19 Vaccines: The Main Pillars of Efficacy
Constantin, C., Pisani, A., Bardi, G., & Neagu, M. T. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0250 · Cited by 15 · see citing works
Sølund, C. S., Underwood, A. P., Fernandez-Antunez, C., Bollerup, S., Mikkelsen, L. S., Villadsen, S. L., Fahnøe, U., Winckelmann, A. A., Feng, S., Vinten, C., et al. (2022) · Vaccines · doi:10.3390/vaccines10010075 · Cited by 15 · see citing works
“Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coron-avirus disease 2019 (COVID-19), emerged in China in December 2019, and on 11 March 2020, the World Health Organization (WHO) recognized the outbreak of this virus as a global pandemic [1,2].”
BackgroundResearch progress of mRNA vaccines for infectious diseases
Zhang, Z., Du, J., Zhang, D., Han, R., Wu, X., & Liang, Y. (2025) · European journal of medical research · doi:10.1186/s40001-025-03060-x · Cited by 16 · see citing works
“BioNTech’s COVID-19 mRNA vaccines (BNT162b1 and BNT162b2) used CleanCap ® capping analogs for vaccine capping [25].”
Wu, X., Lim, J. H. L., Lee, J. S. S., et al. (2021) · JAAD International · doi:10.1016/j.jdin.2021.12.009 · Cited by 11 · see citing works
From Sequence to System: Enhancing IVT mRNA Vaccine Effectiveness through Cutting-Edge Technologies
Xu, L., Li, C., Liao, R., Xiao, Q., Wang, X., Zhao, Z., Zhang, W., Ding, X., Cao, Y., Cai, L., et al. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00863 · Cited by 10 · see citing works
Study of humoral and cellular immunity in vaccinated with mRNA‐1273
Gutiérrez‐Bautista, J. F., López‐Nevot, M. Á., Gómez-Vicente, E., Quesada, T., Marín, E. M., Rodríguez, A. I. E., Rodríguez, A. I. E., Rodríguez‐Granger, J., Cobo, F., & Sampedro, A. (2022) · Apmis · doi:10.1111/apm.13215 · Cited by 9 · see citing works
Immunology of biodegradable nanoparticles: a brief overview on a wide growing field
Pisani, A., & Bardi, G. (2021) · Exploration of Immunology · doi:10.37349/ei.2021.00006 · Cited by 7 · see citing works
González-Meléndez, A., Báez-Negrón, L., Ríos-Rivera, R., et al. (2023) · Lupus · doi:10.1177/09612033231151898 · Cited by 5 · see citing works
Abo-Helo, N., Muhammad, E., Ghaben-Amara, S., et al. (2022) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2022.03.035 · Cited by 3 · see citing works
Rojkovich, B., Németh, D., Török, E., Szabó, B., Pintér, Á., Juhász, I., Weidl, M., Lányi, É., Pável-Szecskó, J., Lázár, I., et al. (2021) · Orvosi Hetilap · doi:10.1556/650.2021.32363 · Cited by 3 · see citing works
Erdoğdu, B., Kaplan, O., Çelebi̇er, M., Malkan, Ü. Y., & Haznedaroğlu, İ. C. (2025) · Medicina · doi:10.3390/medicina61091687 · Cited by 1 · see citing works
Zhang, D., Li, X., Sun, H., et al. (2022) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2022/4270096 · Cited by 1 · see citing works
Zhang, Y., Li, Q., Liu, N., Hu, J., Lin, X., Huang, M., Wei, Y., Qi, X., & Chen, X. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10554
A Possible Blue Print of Addressing mRNA Vaccine Efficacy
Li, B. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v36i.6265
Sumi, T., Kodama, K., Nishikiori, H., et al. (2023) · Cureus · doi:10.7759/cureus.38122
- Authors
- Sahin, U., Muik, A., Derhovanessian, E., Vogler, I., Kranz, L. M., Vormehr, M., Baum, A., Pascal, K., Quandt, J., Maurus, D., Brachtendorf, S., Lörks, V., Sikorski, J., Hilker, R., Becker, D., Eller, A.-K., Grützner, J., Boesler, C., Rosenbaum, C., Kühnle, M.-C., Luxemburger, U., Kemmer-Brück, A., Langer, D., Bexon, M., Bolte, S., Karikó, K., Palanche, T., Fischer, B., Schultz, A., Shi, P.-Y., Fontes-Garfias, C., Perez, J. L., Swanson, K. A., Loschko, J., Scully, I. L., Cutler, M., Kalina, W., Kyratsous, C. A., Cooper, D., Dormitzer, P. R., Jansen, K. U., & Türeci, Ö.
- Affiliations
- BioNTech (Germany) (DE)
- Regeneron (United States) (US)
- Bexon Clinical Consulting (United States) (US)
- Clinical Research Services (DE)
- The University of Texas Medical Branch at Galveston (US)
- Pfizer (United States) (US)
- ORCID
- Sahin, Ugur
- Muik, Alexander
- Vogler, Isabel
- Kranz, Lena M.
- Vormehr, Mathias
- Baum, Alina
- Pascal, Kristen
- Quandt, Jasmin
- Maurus, Daniel
- Lörks, Verena
- Hilker, Rolf
- Becker, Dirk
- Boesler, Carsten
- Kühnle, Marie-Cristine
- Luxemburger, Ulrich
- Bexon, Martin
- Karikó, Katalin
- Shi, Pei-Yong
- Fontes-Garfias, Camila
- Swanson, Kena A.
- Scully, Ingrid L.
- Cutler, Mark
- Kyratsous, Christos A.
- Cooper, David
- Dormitzer, Philip R.
- Jansen, Kathrin U.
- Türeci, Özlem
- Venue
- Nature
- Published
- 2021-01-19
- Volume
- 590
- Issue
- 7844
- Pages
- E17-E17
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W3126136854
- Cited by
- 31
- References
- 0
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 8 · 2022: 11 · 2021: 8
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Keywords
- COVID-19 vaccines, SARS-CoV-2, humoral immune response, antibody response, Th1 response, vaccine immunogenicity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
